News

UltraGene Combo2Screen SARS-CoV-2 Assay Now Supported by French ANSM

Luxembourg (Luxembourg), Metz (France), Boston (USA) — May 13 — Advanced Biological Laboratories (ABL) announced today that its RT-PCR test for COVID-19 detection UltraGene® Combo2Screen SARS-CoV-2 assay is now officially approved by the French ANSM (Agence nationale de sécurité du médicament) as a…

Read more

UltraGene Combo2Screen SARS-CoV-2 Assay Now CE-IVD Marked

Luxembourg (Luxembourg), Metz (France), Boston (USA) — May 7— Advanced Biological Laboratories (ABL) announced today the CE-IVD marking of its UltraGene® Combo2Screen SARS-CoV-2 assay is now available for in-vitro diagnostics use. This test is intended to be used for the qualitative detection of nuc…

Read more

Latest Updates on ABL Solutions for SARS-CoV-2 Diagnostics

Involved in fight against the new Coronavirus, Covid-19, ABL announces the immediat release of new products :  UltraGene Combo 3 genes CoV-2 Assay : 3 targeted genes : RdRp & N-gene for detection, E-gene for confirmation UltraGene-CoV-2-Combo-2 : 2 targeted genes : RdRp & N-gene  UltraGene E…

Read more

Major Updates on HIV Genotyping

ABL is pleased to announce two major updates on its HIV Genotyping Software applications : the full integration of the ViroScore® and DeepChek® software applications with Nadis the availability of a new web-based and disease-specific chromatogram editor

Read more

Connexion du logiciel ViroScore®-HIV (CE IVD) à Nadis disponible

Nous avons le plaisir de vous annoncer que l’intégration du logiciel ViroScore®-HIV (CE IVD) à la plateforme Nadis est disponible. Cette intégration permet à l’ensemble des utilisateurs Nadis de bénéficier de fonctionnalités avancées pour le génotypage du VIH: Synchronisation bidirectionnelle des do…

Read more

ABL Announces Distribution Agreement with Hydrox SIA in Latvia

Advanced Biological Laboratories (ABL) S.A. and ILC – Hydrox SIA are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Latvia. See current channel partners.

Read more
#